The way forward for Ketamine and Mood Disorders In 2019, the FDA and European Fee authorised using an esketamine nasal spready under the brand identify Spravato to take care of despair. On the other hand, as of 2021, ketamine has not been accredited through the FDA to treat depression or https://sandrah651zhv9.wikiexpression.com/user